Company Overview and News
Commercial Bank of Ceylon PLC won the coveted ‘Cyril Gardiner Memorial Trophy’ Gold Award for Overall Excellence in Annual Financial Reporting at the grand finale of the 53rd Annual Report Awards Competition organized by the Institute of Chartered Accountants of Sri Lanka (CA Sri Lanka).
(PRESS RELEASE) – Group turnover for the 9 months of the financial year 2016/17 was 18 billion rupees, compared to 16 billion rupees for the same period of the previous year. The Hand Protection sector contributed Rs.11 billion to the Group’s top line, while the Plantation sector recorded a turnover of 7 billion rupees for the period.
Group turnover for the 1st half of the financial year was Rs. 11.5 billion, compared to Rs.10.9 billion for the same period of the previous year. The Hand Protection sector contributed a modest Rs 7.0 billion to the Group’s top line, while the Plantation sector recorded a turnover of Rs. 4.5 billion for the period.
(PRESS RELEASE) – Group turnover for the 1st half of the financial year was Rs. 11.5 billion, compared to Rs.10.9 billion for the same period of the previous year. The Hand Protection sector contributed a modest Rs 7.0 billion to the Group’s top line, while the Plantation sector recorded a turnover of Rs. 4.5 billion for the period.
Dipped Products PLC (DPL), Sri Lanka’s leading non-medical glove exporter, was recognised as the Highest Value Added Exporter in the Rubber and Rubber Based Product Sector in the recently concluded Presidential Export Award for 2014. Organised by the Export Development Board (EDB) under the auspices of His Excellency the President Maithripala Sirisena, the awards recognise the exponential contribution made by Sri Lankan Exporters to the national economy and to bolster foreign trade for the years 2014 and 2015.
Dipped Products PLC (DPL) posted Rs. 5.4 billion in Group Turnover during the 1Q 2016-17, compared to Rs.5.7 billion for the same period of the previous year. Group Profit before Tax (PBT) for the period was Rs. 12.5 million, fromRs. 176 million recorded for the 1Q last year.
May 25, 2016 (LBO) – Dipped Products, a subsidiary of the Hayleys Group, today announced that it acquired the remaining stake of Italian glove marketer Icoguanti SpA for 535 million rupees.
20h - Asif
Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...
21h - Asif
Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...